Title:
ＬＡＣＴＯＢＡＣＩＬＬＵＳＦＥＲＭＥＮＴＵＭ（ラクトバチルス・ファーメンタム）ＭＥ−３を用いる治療方法
Document Type and Number:
Japanese Patent JP6484561
Kind Code:
B2
Abstract:
The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component, a metabolic syndrome related disorder selected from prediabetes, type 2 diabetes and cardiovascular disease. The effect may be achieved by simultaneously: decreasing the level of glycated haemoglobin HbA1c, decreasing or preventing low-grade inflammation on a cellular level and increasing the level of adiponectin.
Inventors:
Kurisar, tiou
Zilmer, Mifkel
Sumido, Imbi
Zilmer, Kelsty
Michelsaal, Marika
Foot, pilje
Zilmer, Mifkel
Sumido, Imbi
Zilmer, Kelsty
Michelsaal, Marika
Foot, pilje
Application Number:
JP2015548871A
Publication Date:
March 13, 2019
Filing Date:
December 20, 2013
Export Citation:
Assignee:
University of Tartu
International Classes:
A61K35/747; A23C9/12; A23C9/15; A23C19/00; A23G1/00; A23L33/10; A23L33/135; A61K31/366; A61P3/02; A61P3/10; A61P7/00; A61P9/00; A61P29/00; A61P43/00
Domestic Patent References:
| JP9176005A |
Foreign References:
| US20040151708 |
Other References:
Microb. Ecol. Health Dis.,2009年,Vol.21,pp.1-27
Mayo Clin. Proc.,2008年,Vol.83 No.7,pp.758-764
Lab. Clin. Pract.,2002年,Vol.20 No.1,pp.10-16
Cent. Eur. J. Biol.,2011年,Vol.6 No.1,pp.32-40
Mayo Clin. Proc.,2008年,Vol.83 No.7,pp.758-764
Lab. Clin. Pract.,2002年,Vol.20 No.1,pp.10-16
Cent. Eur. J. Biol.,2011年,Vol.6 No.1,pp.32-40
Attorney, Agent or Firm:
Yusuke Hiraki
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Naoko Kikuta
Wataru Ueda
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Naoko Kikuta
Wataru Ueda